EE490 Adverse Event (AE) Management Costs Associated With Immune Checkpoint Inhibitors (ICI) Approved for Various Advanced or Metastatic Cancers in the US
Abstract
Authors
S Ranjan J Gandhi R Mothe T Werwath R Ameen M Kk K Sagar R Potluri